Anti-TNF alpha medications and neuropathy.

Details

Serval ID
serval:BIB_DA553F1DD0E2
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Anti-TNF alpha medications and neuropathy.
Journal
Journal of the Peripheral Nervous System : Jpns
Author(s)
Tsouni P., Bill O., Truffert A., Liaudat C., Ochsner F., Steck A.J., Kuntzer T.
ISSN
1529-8027 (Electronic)
ISSN-L
1085-9489
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
20
Number
4
Pages
397-402
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
We studied the clinical, electrophysiological, and pathological features, outcome, and frequency of anti-tumor necrosis factor alpha (a-TNF) medications-induced neuropathies (ATIN) in patients with inflammatory disorders. Of 2,017 patients treated with a-TNF medication, 12 patients met our inclusion criteria for a prevalence of 0.60% and an incidence of 0.4 cases per 1,000 person-years. The median time from a-TNF medication treatment to ATIN was 16.8 months (range 2-60 months). Six patients had focal or multifocal peripheral neuropathies. The other six had generalized neuropathies. For all, a-TNF medication was stopped. Seven patients received immunoglobulin infusions. ATIN outcome was favorable in all but one patient. ATINs are rare and heterogeneous neuropathies. In 10 patients, the neuropathy was "inflammatory", suggesting that it could be due to systemic pro-inflammatory effects of a-TNF agents.
Keywords
Adalimumab/adverse effects, Adalimumab/therapeutic use, Adult, Aged, Autoimmune Diseases/drug therapy, Electrodiagnosis, Etanercept/adverse effects, Etanercept/therapeutic use, Female, Humans, Infliximab/adverse effects, Infliximab/therapeutic use, Male, Middle Aged, Neural Conduction/physiology, Peripheral Nervous System Diseases/chemically induced, Peripheral Nervous System Diseases/diagnosis, Rheumatic Diseases/drug therapy, Tumor Necrosis Factor-alpha/antagonists & inhibitors
Pubmed
Web of science
Create date
19/02/2016 18:47
Last modification date
20/08/2019 15:59
Usage data